Laws and sections by number or title, due dates, pages, and updates.
The Employees State Insurance Corporation extends the existing DG ESIC Rate Contract No. Ay. 9 for AYUSH drugs from 17.11.2025 to 16.01.2026 or until the finalization of the new rate contract. Officials apply the extension under specific conditions. The firm must show willingness to supply on the same terms and conditions. The authority prohibits placing orders for drugs found not of standard quality on test analysis. Officials place supply orders only to first preference holders according to the attached revised list of L-1 drugs and consider previous amendments or orders.
What you must do
Key dates
Who is affected
Ask about this circular
आयुषु प्रभाग Headquarters Office EMPLOYEES’ STATE INSURANCE CORPORATION Ministry of Labour & Employment, Govt. of India Panchdeep Bhawan: C.I.G. Road, New Delhi – 110002 Tel.: 011-23604734, e-mail: dmc-ism@esic.gov.in , ayush-hq@esic.gov.in, mc-ayush.hq@esic.nic.in
File No. U-16013/141/2022-AYUSH-Part (2)
Date: 23.12.2025
To,
The Deans - All PGIMSR / ESIC Medical College & Hospitals
The Medical Superintendent – All ESIC Hospitals
The Director (Medical) Delhi/Noida
The Director, ESI Scheme –All States
Regional Director - All States
Subject: Extension of DG ESIC Rate Contract No. Ay. 9 issued vide No.U-16/13/6/Ayur.-9/2022-AYUSH dated 17.11.2023
Madam/Sir,
Kindly refer to this office e-mail dated 19.12.2025 and letter of even number dated 19.12.2025, on the subject cited above along with the list of L-1 drugs approved under DG ESIC Rate Contract no. Ay.-9.
In the letter dated 19.12.2025, the approval of Director General ESIC for extension of existing DG ESIC Rate Contract No. Ay.9 w.e.f 17.11.2025 to 16.01.2026 or until the finalization of the new Rate Contract, whichever is earlier is conveyed subject to the following terms & conditions:
Willingness of the firm to supply on the same terms and conditions as approved in rate contract No. Ay.9.
No order should be placed in respect of drugs, which have been found "Not of Standard Quality" on test analysis.
Supply order should be placed only to first preference holders as per the list attached.
Amendments /orders (if any) already issued time to time in r/o items /firms of Rate Contract No. Ay.9 to be taken into consideration while placing the supply orders.
In this connection, it is to inform you to please ignore the list of L-1 drugs attached with the e-mail dated 19.12.2025
The revised list of L-1 drugs approved under DG ESIC Rate Contract no. Ay.-9 is attached for your information and further necessary action.
This is issued with approval Competent Authority
Yours sincerely,
Digitally signed by
Pawan Kumar
Date: 23-12-2025
17:32:49
(Dr. Pawan Kumar)
DMC (AYUSH)
Copy to:
